In summary, we identified that the NLRP3 inflammasome is activated in CpG-induced hyperinflammation and critical for enhanced production of IL-18, a key driver of hyperinflammatory disease in patients diagnosed with MAS. This evidence concerns the gene NLRP3 and macrophage activation syndrome.